Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | PNMT | P11086 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | VNN1 | O95497 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cericlamine SCHEMBL4747551 | 1.00 | FDPS (0.45) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| Cericlamine SCHEMBL29359640 | 1.00 | FDPS (0.45) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| Cericlamine SCHEMBL29486910 | 0.98 | FDPS (0.44) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| Cericlamine SCHEMBL140391 | 0.98 | FDPS (0.44) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| SCHEMBL10771931 | 0.86 | SIGMAR1 (0.42) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| SCHEMBL10771519 | 0.85 | FDPS (0.44) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| SCHEMBL9130196 | 0.81 | FDPS (0.38) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| SCHEMBL9130190 | 0.81 | FDPS (0.38) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| Hydrochloric Acid SCHEMBL9422892 | 0.80 | FDPS (0.38) | FDPSSIGMAR1MEN1ALDH1A1TP53 | |
| SCHEMBL9776021 | 0.76 | PNMT (0.42) | FDPSSIGMAR1MEN1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2723 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514883-B2 | Compositions and methods for modulating lipid and steroid metabolism | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-06 | — | — | US | claimed |
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |
| EP-4536231-A1 | TREATMENT OF ANTIDEPRESSANT RESISTANT SUBJECTS | Actinogen Medical Limited (AU) | 2025-04-16 | — | — | EP | claimed |
| WO-2023235937-A1 | TREATMENT OF ANTIDEPRESSANT RESISTANT SUBJECTS | Actinogen Medical Limited (AU) | 2023-12-14 | — | — | WO | claimed |
| US-20230381168-A1 | ADJUNCTIVE THERAPY FOR DEPRESSION | ANEUROTECH BV (BE) | 2023-11-30 | — | — | US | claimed |
| US-20220347127-A1 | USE OF ANTIDEPRESSANT AGENTS FOR PREVENTING AND TREATING THE COVID-19 DISEASE | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) | 2022-11-03 | — | — | US | claimed |
| US-20220265641-A1 | SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONIST | ATLAS PHARMACEUTICALS BV (BE) | 2022-08-25 | — | — | US | claimed |
| WO-2022159506-A1 | DEUTERATED CANNABIDIOL COMPOUNDS | MERIT THERAPEUTICS, INC. (US) | 2022-07-28 | — | — | WO | claimed |
| WO-2022159507-A1 | COMBINATION OF CANNABINOIDS WITH ADDITIONAL THERAPEUTIC AGENTS FOR TREATING DISEASES OR DISORDERS | MERIT THERAPEUTICS, INC. (US) | 2022-07-28 | — | — | WO | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| EP-0977558-A2 | USE OF 5HT4 RECEPTOR ANTAGONISTS FOR OVERCOMING GASTROINTESTINAL EFFECTS OF SEROTONIN REUPTAKE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-02-09 | — | — | EP | claimed |
| EP-0973724-A1 | NOVEL PROCESS FOR THE PREPARATION OF (+/-)3- (3,4-DICHLOROPHENYL)-2- DIMETHYLAMINO-2-METHYLPROPAN-1-OL OR CERICLAMINE (INN) | PARKE-DAVIS (FR) | 2000-01-26 | — | — | EP | claimed |
| US-5990159-A | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors | JANSSEN PHARMACEUTICA, N.V. (BE) | 1999-11-23 | — | — | US | claimed |
| US-5977099-A | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors | AKZO NOBEL, N.V. (NL) | 1999-11-02 | — | — | US | claimed |
| WO-1998045248-A1 | NOVEL PROCESS FOR THE PREPARATION OF (+/-)3- (3,4-DICHLOROPHENYL)-2- DIMETHYLAMINO-2-METHYLPROPAN-1-OL OR CERICLAMINE (INN) | JOUVEINAL (FR) | 1998-10-15 | — | — | WO | claimed |
| CN-1173330-A | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors | AKZO NOBEL NV (NL) | 1998-02-18 | — | — | CN | claimed |
| EP-0813873-A1 | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors | Akzo Nobel N.V. (NL) | 1997-12-29 | — | — | EP | claimed |
| WO-1997029739-A2 | USE OF 5HT4 RECEPTOR ANTAGONISTS FOR OVERCOMING GASTROINTESTINAL EFFECTS OF SEROTONIN REUPTAKE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-08-21 | — | — | WO | claimed |
| WO-1992000103-A1 | PHARMACEUTICAL PREPARATIONS | BEECHAM GROUP PLC (GB) | 1992-01-09 | — | — | WO | claimed |
| US-4994617-A | Analgesics | JOUVEINAL S.A. (FR) | 1991-02-19 | — | — | US | claimed |